FDA v. Alliance for Hippocratic Medicine
✓DecidedDocket:23-719
Fifth Circuit
Argued March 26, 2024
Decided June 13, 2024
Question Presented
Whether respondents have Article III standing to challenge FDA's 2016 and 2021 regulatory actions regarding mifepristone.
Plain English Summary
The Court unanimously held that the plaintiffs lacked standing to challenge FDA actions expanding access to the abortion drug mifepristone. The doctors and organizations failed to show they suffered concrete injury from the FDA's decisions.
In the News
Case Timeline
Certiorari Granted
Supreme Court agreed to hear the case
Oral Arguments
⚖️Case argued before the Court
Mar 26, 2024
Opinion Issued
✓Court's decision released
Jun 13, 2024